Impact of Center Volume on Access to Pancreas Transplantation and Waiting List Mortality: A 25-y Eurotransplant Experience
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background: Pancreas transplantation remains among the few treatments able to restore sustained insulin independence in selected patients with type 1 diabetes mellitus, yet annual transplant numbers have declined across the Eurotransplant region. Previous work has linked center volume to posttransplant graft and patient survival, but its influence on access to transplantation and waiting list mortality remains incompletely characterized. Methods: We performed a retrospective cohort study of 6672 patients listed for vascularized pancreas transplantation within Eurotransplant between 2000 and 2024. Centers were classified each year by tertile of annual transplant volume into low-, medium-, and high-volume categories. Cumulative incidence functions for transplantation and waiting list mortality were estimated using the Aalen-Johansen estimator. Cause-specific time-varying Cox proportional hazards models were fitted, adjusting for recipient age, sex, blood group, country, registration year, and waiting list size. Results: Overall, 4410 patients (66.1%) received a transplant and 655 (9.8%) died on the waiting list. Compared with low-volume centers, listing at medium-volume (hazard ratio [HR], 1.13; 95% confidence interval [CI], 1.01-1.27) and high-volume centers (HR, 1.30; 95% CI, 1.16-1.45) was independently associated with a higher probability of transplantation. Waiting list mortality was also lower at medium-volume (HR, 0.70; 95% CI, 0.53-0.92) and high-volume centers (HR, 0.70; 95% CI, 0.55-0.90). Conclusions: Within Eurotransplant, patients listed at low-volume pancreas transplant centers face a dual disadvantage of reduced access to transplantation and higher waiting list mortality, with implications for allocation policy, center designation, and patient referral.
Source: Transplantation Direct
Authors: Mando Dyko Filipe, Milou van Bruchem, Helmut Arbogast, Erwin de Buijzer, Pieter Gillard, Georg Györi, Stipislav Jadrijevic, Axel Jens, Daniel Jacobs-Tulleneers-Thevissen, Andreas Kahl, Barbara Ludwig, Cyril Moers, Miha Petric, Mirko Poljak, Andreas Schnitzbauer, Philipp Stiegler, Peter Szakaly, Hans-Michael Tautenhahn, Gabor Telkes, Ales Tomazic, Thomas Vogel, Volkert Huurman, Robert Öllinger
Institutions: Eurotransplant, Ludwig-Maximilians-Universität München, Universitair Ziekenhuis Leuven, Medical University of Vienna, Klinička bolnica Merkur, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Charité – Universitätsmedizin Berlin, University Hospital Carl Gustav Carus, University Medical Center Groningen, Ljubljana University Medical Centre, Universitätsklinikum Knappschaftskrankenhaus Bochum, Ruhr University Bochum, Medical University of Graz, University of Pecs, University Hospital Leipzig, Semmelweis University, Universitätsklinikum Aachen, Leiden University Medical Center
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,200
OpenAlex ID: W7234544834
